✦ LIBER ✦

248 Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

✍ Scribed by A. Hrzenjak; F. Moinfar; M.L. Kremser; B. Strohmeier; E. Petru; K. Zatloukal; H. Denk

Book ID: 119602035
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)71055-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significant growth suppression of synovi

Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo

✍ Tatsuo Ito; Mamoru Ouchida; Yuki Morimoto; Aki Yoshida; Yoshimi Jitsumori; Toshi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 429 KB

The histone deacetylase inhibitor belino

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

✍ Michael T Buckley; Joanne Yoon; Herman Yee; Luis Chiriboga; Leonard Liebes; Guls 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 991 KB

In vitro and in vivo histone deacetylase

In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?

✍ Susan C. Modesitt; Sarah J. Parsons 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Histone deacetylase inhibitor, FK228, in

Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo

✍ Hiroki Sawa; Hiromi Murakami; Masaoki Kumagai; Matsuyoshi Nakasato; Shigeru Yama 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 508 KB

The histone deacetylase inhibitor valpro

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo

✍ Jon Jones; Eva Juengel; Ausra Mickuckyte; Lukasz Hudak; Steffen Wedel; Dietger J 📂 Article 📅 2008 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 900 KB

Inhibitors of histone deacetylases in cl

Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro

✍ M.D. Cantley; D.P. Fairlie; P.M. Bartold; K.D. Rainsford; G.T. Le; A.J. Lucke; C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

Histone deacetylase inhibitors (HDACi) suppress cancer cell growth, inflammation, and bone resorption. The aim of this study was to determine the effect of inhibitors of different HDAC classes on human osteoclast activity in vitro. Human osteoclasts generated from blood mononuclear cells stimulated